Short COurse PrimaquinE for the radical cure of P. vivax (SCOPE)

Tahapan Penelitian : Initial
Sponsor:
Mitra Pelaksana:
Menzies School of Health Research, Australia Burnet Institute, Australia Institute of Tropical Medicine, Belgium University of Melbourne
No Registry
INA-2NWRPQ47
Tanggal Input Registry : 25-03-2025

25-03-2025
Proportion of patients experiencing at least one SAE or AESI during treatment
The proportion of patients experiencing AESI, stopping PQ before completion, receiving correct treatment based on G6PD activity, or reviewed on day 3 and day 7
 
Short COurse PrimaquinE for the radical cure of P. vivax (SCOPE)
Feasibility of high daily dose short course primaquine after G6PD testing for the radical cure of Plasmodium vivax malaria
Interventional
Primaquine
500
 

Inclusion Criteria:

Patients diagnosed with P. vivax malaria Patients eligible for PQ (Primaquine) treatment G6PD Activity >70% → Eligible for PQ7 G6PD Activity 30-70% → Eligible for PQ14 G6PD Activity

Exclusion Criteria:

Pregnant women (confirmed or unknown pregnancy status), Lactating women, Infants younger than 6 months or weighing
 
Pending
Not applicable
Not applicable
Vicky Achmad Ginanjar